Colchicine: Uses, Dosage & Side Effects
Antigout medication for treating and preventing gout attacks and Familial Mediterranean Fever (FMF)
📊 Quick Facts About Colchicine
💡 Key Takeaways About Colchicine
- Narrow therapeutic index: There is only a small difference between an effective dose and a toxic dose – never exceed your prescribed amount
- Early treatment is key: Colchicine works best for gout attacks when started within 12 hours of symptom onset
- Stop if GI symptoms appear: Nausea, vomiting, or diarrhea may signal toxicity – stop taking colchicine and contact your doctor immediately
- Dangerous drug interactions: Certain antibiotics (macrolides), antifungals, and HIV protease inhibitors can cause life-threatening colchicine toxicity
- Dual purpose medication: Used for both acute gout treatment and long-term prevention of FMF attacks and amyloidosis
What Is Colchicine and What Is It Used For?
Colchicine is an anti-inflammatory medication derived from the autumn crocus plant (Colchicum autumnale) that is used to treat and prevent acute gout attacks in adults. It is also the cornerstone treatment for Familial Mediterranean Fever (FMF), where it prevents recurring fever episodes and the development of amyloidosis.
Colchicine belongs to the group of medicines known as antigout agents and has been used in medicine for centuries. Unlike typical painkillers such as NSAIDs (non-steroidal anti-inflammatory drugs) or corticosteroids, colchicine targets the specific inflammatory pathways involved in crystal-induced inflammation, making it uniquely effective for conditions where crystal deposition drives the disease process.
The medication works by binding to a protein called tubulin, which prevents the assembly of microtubules inside cells. This action has several important downstream effects: it inhibits the activation of the NLRP3 inflammasome (a key driver of the inflammatory response to uric acid crystals), reduces the migration and adhesion of neutrophils (white blood cells that accumulate in inflamed joints), and decreases the production of pro-inflammatory signaling molecules such as interleukin-1 beta (IL-1β).
Gout Treatment and Prevention
Gout is a form of inflammatory arthritis caused by elevated levels of uric acid in the blood (hyperuricemia). When uric acid levels become too high, crystals of monosodium urate can form and deposit in joint fluid, causing sudden and intense episodes of pain, swelling, redness, and tenderness – known as gout attacks or gout flares. The big toe is the most commonly affected joint, though gout can occur in any joint including the ankles, knees, wrists, and fingers.
Colchicine is used in two distinct ways for gout management. For acute gout attacks, it is taken as short-term treatment to reduce the inflammation and pain of an active flare. It is most effective when taken as early as possible after symptoms begin, ideally within the first 12 hours. For gout prophylaxis, low-dose colchicine is taken daily on a long-term basis to prevent recurrent flares, particularly when initiating urate-lowering therapy (such as allopurinol) which can paradoxically trigger gout attacks during the first months of treatment.
Familial Mediterranean Fever (FMF)
Familial Mediterranean Fever is a hereditary autoinflammatory disorder characterized by recurrent episodes of fever accompanied by painful inflammation of the abdomen, chest, or joints. The condition primarily affects people of Mediterranean descent, including those of Turkish, Armenian, Arab, and Jewish ancestry. Without treatment, FMF can lead to a serious complication called AA amyloidosis, where abnormal protein deposits accumulate in organs – particularly the kidneys – potentially leading to kidney failure.
Colchicine is the first-line and most important treatment for FMF. When taken regularly, it effectively prevents fever attacks in the majority of patients and, crucially, prevents the development of amyloidosis. The European League Against Rheumatism (EULAR) and other international guidelines strongly recommend lifelong colchicine therapy for all patients diagnosed with FMF, regardless of the frequency of their attacks.
Colchicine does not lower uric acid levels. It reduces the inflammation caused by uric acid crystals but does not address the underlying cause of gout. Long-term gout management typically requires urate-lowering medications such as allopurinol or febuxostat in addition to colchicine.
What Should You Know Before Taking Colchicine?
Before taking colchicine, you must inform your doctor about any liver or kidney problems, heart disease, gastrointestinal disorders, or blood conditions. Colchicine is contraindicated in patients with severe kidney or liver impairment and those with serious blood disorders. Women of childbearing age must use contraception during and for 3 months after treatment.
Colchicine requires careful medical supervision because of its narrow therapeutic index – the margin between an effective dose and a potentially toxic dose is very small. This means that even a slightly excessive dose can produce signs of drug toxicity. Your prescribing physician will consider your overall health, other medications, and kidney and liver function before determining the appropriate dose for you.
Contraindications
You must not take colchicine if any of the following apply to you:
- Allergy to colchicine or any of the other ingredients in the tablet (including lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate)
- Severe blood disorders such as bone marrow suppression or significantly reduced blood cell counts
- Severe kidney impairment (significantly reduced kidney function or renal failure)
- Severe liver impairment (advanced liver disease or cirrhosis)
Warnings and Precautions
Talk to your doctor or pharmacist before using colchicine if any of the following situations apply to you, either now or in the past:
- Mild to moderate kidney or liver problems: Your dose may need to be reduced and you will require closer monitoring
- Cardiovascular disease: Heart conditions may require special consideration when prescribing colchicine
- Gastrointestinal problems: Pre-existing stomach or intestinal conditions may increase the risk of gastrointestinal side effects
- Elderly and frail patients: Increased sensitivity to colchicine effects requires careful dose adjustment
- Blood disorders: Any existing blood condition may be worsened by colchicine
Colchicine can cause serious deterioration of bone marrow function, leading to a reduction in white blood cells (agranulocytosis), platelet deficiency (thrombocytopenia), or reduced red blood cell production (aplastic anemia). You will need regular blood tests to monitor for these changes. If you develop symptoms such as fever, mouth sores, sore throat, prolonged bleeding, bruising, or skin problems, stop taking colchicine and contact your doctor immediately.
Long-term use of colchicine can lead to vitamin B12 deficiency because colchicine may reduce the absorption of vitamin B12 from the gastrointestinal tract. Your doctor may monitor your B12 levels during prolonged treatment and recommend supplementation if necessary.
Pregnancy and Breastfeeding
The use of colchicine during pregnancy and breastfeeding requires careful medical consideration and differs depending on the condition being treated:
For gout treatment: Colchicine should not be used during pregnancy or by women who may become pregnant. Women of childbearing potential must use effective contraception during treatment and for at least 3 months after stopping colchicine. Male patients should not father a child during treatment and for at least 6 months after stopping colchicine. If pregnancy occurs during this period, discuss the potential risks with your doctor immediately.
For Familial Mediterranean Fever: Since untreated FMF can itself negatively affect pregnancy outcomes (including increased risk of miscarriage and complications), the use of colchicine during pregnancy may be considered when the clinical benefit outweighs the potential risks. This decision should be made in close consultation with your specialist physician. Current evidence from large observational studies suggests that colchicine exposure during pregnancy for FMF does not significantly increase the risk of major birth defects, though careful monitoring is recommended.
Breastfeeding: Colchicine passes into breast milk. For gout treatment, colchicine should not be used while breastfeeding. For FMF, a decision must be made weighing the benefit of breastfeeding against the benefit of continued treatment. Consult your doctor for individual guidance.
Driving and Operating Machinery
There are no specific studies on whether colchicine affects the ability to drive or operate machinery. However, drowsiness and dizziness are potential side effects that should be taken into account. Do not drive or operate heavy machinery if you experience these symptoms.
How Does Colchicine Interact with Other Drugs?
Colchicine has potentially life-threatening interactions with certain antibiotics (macrolides), antifungal medications (azoles), HIV protease inhibitors, and several heart medications. These drugs inhibit the enzymes that metabolize colchicine, leading to dangerous increases in colchicine blood levels. Additionally, statins and fibrates taken with colchicine can cause severe muscle damage (rhabdomyolysis).
Drug interactions with colchicine are particularly dangerous because of its narrow therapeutic index. Many commonly prescribed medications can significantly increase colchicine concentrations in the blood by inhibiting the CYP3A4 enzyme and/or P-glycoprotein transport systems that are responsible for metabolizing and eliminating colchicine from the body. Even modest increases in colchicine blood levels can push the concentration from therapeutic to toxic ranges.
Always tell your doctor or pharmacist about all medications you are currently taking, have recently taken, or plan to take. This includes prescription drugs, over-the-counter medications, herbal supplements, and vitamins.
Major Interactions – Avoid Combination
The following medications can cause severe, potentially life-threatening colchicine toxicity and should generally not be used together with colchicine:
| Drug/Class | Examples | Risk | Action |
|---|---|---|---|
| Macrolide antibiotics | Erythromycin, clarithromycin, telithromycin, azithromycin | Increased colchicine toxicity via CYP3A4 inhibition | Avoid if possible; if unavoidable, reduce colchicine dose with close monitoring |
| Azole antifungals | Ketoconazole, itraconazole, voriconazole | Severe colchicine toxicity via strong CYP3A4 inhibition | Do not use together |
| HIV protease inhibitors | Ritonavir, atazanavir, saquinavir, nelfinavir, indinavir | Severe colchicine toxicity via strong CYP3A4 and P-gp inhibition | Do not use together |
| Calcium channel blockers | Verapamil, diltiazem | Increased colchicine levels via P-glycoprotein inhibition | Dose reduction and monitoring required |
| Cyclosporine | Cyclosporine (immunosuppressant) | Increased colchicine toxicity and potential nephrotoxicity | Avoid combination; close monitoring if essential |
Moderate Interactions – Use with Caution
The following medications require special caution when used with colchicine due to the risk of serious adverse effects:
| Drug/Class | Examples | Risk |
|---|---|---|
| Statins | Simvastatin, fluvastatin, pravastatin | Increased risk of myopathy and rhabdomyolysis (severe muscle damage with dark urine) |
| Fibrates | Fenofibrate, gemfibrozil | Increased risk of myopathy and rhabdomyolysis |
| Digoxin | Digoxin (heart medication) | Potential increased risk of muscle toxicity |
| Quinidine | Quinidine (antiarrhythmic) | Increased colchicine levels via P-glycoprotein inhibition |
| Cimetidine | Cimetidine (stomach acid reducer) | May enhance colchicine effects |
| Vitamin B12 | Cyanocobalamin supplements | Colchicine may reduce B12 absorption from the gut |
Do not drink grapefruit juice while taking colchicine. Grapefruit juice inhibits CYP3A4 enzymes in the gut and liver, which can significantly increase colchicine blood levels and raise the risk of toxicity.
What Is the Correct Dosage of Colchicine?
For acute gout attacks, the recommended adult dose is 500 micrograms two to three times daily, with a maximum of 6,000 micrograms per treatment course. For gout prevention, the dose is 500–1,000 micrograms daily taken in the evening. For FMF, the dose ranges from 1,000 to 3,000 micrograms daily. Always follow your doctor's prescribed dosage exactly.
Always use colchicine exactly as your doctor or pharmacist has directed. Colchicine can be toxic in excessive doses, so it is critical not to exceed the amount prescribed. If you are unsure about your dose, consult your doctor or pharmacist. Pay careful attention to which tablet strength you have been prescribed.
Adults – Gout Treatment
Acute Gout Attack
- Recommended dose: 500 micrograms two to three times daily
- Your doctor may prescribe an additional 1,000 micrograms on the first day of treatment
- Stop treatment if gastrointestinal symptoms develop (nausea, vomiting, diarrhea) or if no improvement after 2–3 days
- Maximum per course: Do not take more than 6,000 micrograms total during a treatment course
- Waiting period: After completing a course, wait at least 3 days before starting a new course
Gout Prevention (Prophylaxis)
- Recommended dose: 500–1,000 micrograms per day, taken in the evening
- Your doctor will advise on the duration of prophylactic treatment
- Often prescribed when starting urate-lowering therapy (e.g., allopurinol) to prevent flares
Adults – Familial Mediterranean Fever (FMF)
FMF in Adults
- Recommended dose: 1,000–3,000 micrograms per day
- May be taken as a single daily dose or divided into two doses (for doses above 1,000 micrograms/day)
- If symptoms persist, your doctor may gradually increase the dose up to a maximum of 3,000 micrograms/day
- Close monitoring for side effects is required when doses are increased
Children – Familial Mediterranean Fever Only
Colchicine should not be used for gout treatment in children and adolescents. For FMF, dosing is based on age and should only be prescribed under specialist supervision:
| Age Group | Daily Dose | Notes |
|---|---|---|
| Under 5 years | 500 micrograms/day | Specialist supervision required; oral solution may be prescribed for infants under 1 year |
| 5 to 10 years | 1,000 micrograms/day | May be divided into two doses |
| Over 10 years | 1,500 micrograms/day | May be increased to 2,000 micrograms/day for amyloid nephropathy |
Elderly Patients
Elderly patients, particularly those who are frail or have reduced kidney or liver function, may be more sensitive to the effects of colchicine. Dose adjustments are typically made based on kidney and liver function rather than age alone, though careful monitoring is recommended in all elderly patients. Your doctor will determine the safest effective dose for your situation.
Patients with Kidney or Liver Impairment
If you have mild to moderate kidney or liver impairment, the recommended dose is 500 micrograms per day with close monitoring. If you have severe kidney or liver impairment, colchicine should not be used (see Contraindications above). For FMF patients with impaired kidney or liver function, the recommended dose is halved.
Missed Dose
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten dose. If you are unsure, consult your doctor or pharmacist.
Overdose
If you or someone else has taken too much colchicine, contact emergency services or a poison control center immediately, even if you feel fine. Colchicine overdose is life-threatening. There is no specific antidote.
Early symptoms (may not appear for several hours): burning sensation in throat and stomach, nausea, severe vomiting, abdominal cramps, and bloody diarrhea, which can lead to dehydration, low blood pressure, and shock.
Late complications (24–72 hours after overdose): confusion, delirium, coma, paralysis, respiratory failure, pulmonary edema, kidney failure, bone marrow suppression, and cardiac arrest.
Delayed effects (approximately 7 days later): temporary increase in white blood cells and hair loss may occur in survivors.
Swallow the tablets whole with a glass of water. Colchicine can be taken with or without food. If you experience stomach upset, taking it with a small meal may help. Do not crush or chew the tablets unless instructed by your doctor.
What Are the Side Effects of Colchicine?
The most common side effects of colchicine are gastrointestinal symptoms: nausea, vomiting, abdominal cramps, and diarrhea, which often indicate the dose is approaching toxic levels. Uncommon but serious side effects include muscle weakness (myopathy) and rhabdomyolysis. Rare but severe reactions include bone marrow suppression (agranulocytosis, aplastic anemia) requiring immediate medical attention.
Like all medicines, colchicine can cause side effects, although not everyone experiences them. Because of colchicine's narrow therapeutic index, gastrointestinal side effects are particularly important warning signs – they often appear before more serious toxicity develops and should prompt you to stop taking the medication and contact your doctor.
- Persistent nausea, vomiting, stomach cramps, or diarrhea (may indicate approaching toxicity)
- Muscle weakness, pain, or dark reddish-brown urine (signs of rhabdomyolysis)
- High fever, severe sore throat, or mouth ulcers (signs of blood cell suppression)
- Unusual bleeding, bruising, or skin problems (signs of platelet or blood cell problems)
Side Effects by Frequency
Common
- Nausea
- Vomiting
- Abdominal cramps
- Diarrhea
Uncommon
- Muscle weakness (myopathy)
- Rhabdomyolysis (breakdown of muscle tissue with dark/reddish-brown urine)
- Muscle pain
- Fatigue
Rare
- Aplastic anemia (severe bone marrow failure)
- Infections with symptoms such as high fever, severe sore throat, and mouth ulcers
Frequency Not Known
- Hair loss (alopecia)
- Skin rash
- Reduced sperm count or absence of sperm (azoospermia)
- Sore throat
- Peripheral neuropathy (nerve damage causing pain, numbness, or impaired nerve function)
- Absence of menstruation (amenorrhea) for 6 months or more, and painful menstruation
- Vitamin B12 deficiency
- Liver damage
Children and Adolescents
There are no specific data available on the effects of long-term colchicine use in children and adolescents under 18 years of age. Children treated with colchicine for FMF should be monitored regularly by a specialist physician, including regular blood tests to check for any adverse effects on blood cell counts and organ function.
If you experience any side effects, including those not listed above, talk to your doctor or pharmacist. You can also report side effects directly to your national medicines regulatory authority. By reporting side effects, you contribute to ongoing monitoring of the medication's benefit-risk profile.
How Should You Store Colchicine?
Store colchicine below 25°C (77°F) in its original packaging, protected from light. Keep out of the sight and reach of children. Do not use after the expiration date. Once a bottle is opened, use within 6 months.
Proper storage of colchicine is important to maintain the medication's effectiveness and safety. Follow these storage guidelines:
- Temperature: Store at or below 25°C (77°F). Do not refrigerate or freeze.
- Light protection: Keep the tablets in their original packaging as they are light-sensitive.
- After opening (bottles): If your colchicine comes in a bottle, use within 6 months of first opening.
- Expiration date: Do not use colchicine after the expiration date printed on the carton, label, or blister pack (marked "EXP"). The expiration date refers to the last day of the indicated month.
- Keep out of reach of children: Store in a location where children cannot see or access the medication. Colchicine is particularly dangerous in children who accidentally ingest it.
- Disposal: Do not dispose of unused colchicine in household waste or down the drain. Return unused medication to your pharmacy for safe disposal to help protect the environment.
What Does Colchicine Contain?
Each 500 microgram tablet contains colchicine as the active ingredient. Inactive ingredients include lactose monohydrate, microcrystalline cellulose (E460), sodium starch glycolate, and magnesium stearate (E572). The tablets are pale yellow, round, and marked "0.5" on one side.
Active Ingredient
The active substance is colchicine, an alkaloid originally derived from the autumn crocus plant (Colchicum autumnale). Each tablet contains 500 micrograms (0.5 mg) of colchicine. Modern pharmaceutical colchicine is synthetically produced to ensure consistent purity and potency.
Inactive Ingredients (Excipients)
- Lactose monohydrate – a sugar-based filler. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
- Microcrystalline cellulose (E460) – a plant-derived binding and filling agent
- Sodium starch glycolate – a disintegrant that helps the tablet dissolve properly
- Magnesium stearate (E572) – a lubricant used in tablet manufacturing
Sodium content: This medicine contains less than 1 mmol (23 mg) sodium per tablet, meaning it is essentially sodium-free.
Tablet Appearance and Packaging
Colchicine 500 microgram tablets are pale yellow, round tablets with the inscription "0.5" on one side. They are available in several packaging configurations:
- Blister packs of 12 tablets (1 blister per carton)
- Blister packs of 30 tablets (3 blisters of 10 per carton)
- Blister packs of 100 tablets (10 blisters of 10 per carton)
- White plastic bottle of 250 tablets in a carton
Frequently Asked Questions About Colchicine
Medical References and Sources
This article is based on current medical research, international guidelines, and approved prescribing information. All claims are supported by scientific evidence from peer-reviewed sources.
- European Medicines Agency (EMA). "Colchicine – Summary of Product Characteristics (SmPC)." European Medicines Agency Official European prescribing information and safety data.
- EULAR (2024). "2023 EULAR recommendations for the management of gout." Annals of the Rheumatic Diseases. doi:10.1136/ard-2023-224702 European League Against Rheumatism updated gout management guidelines. Evidence level: 1A
- American College of Rheumatology (2020). "2020 ACR Guidelines for Management of Gout." Arthritis Care & Research. 72(6):744-760. doi:10.1002/acr.24180 American College of Rheumatology guidelines for gout management including colchicine dosing.
- British National Formulary (BNF). "Colchicine – Drug Monograph." BNF/NICE UK national prescribing reference for colchicine dosing and interactions.
- World Health Organization (WHO) (2023). "Model List of Essential Medicines – 23rd List." WHO Essential Medicines Colchicine is included on the WHO Model List of Essential Medicines.
- Terkeltaub RA, et al. (2010). "High versus low dosing of oral colchicine for early acute gout flare." Arthritis & Rheumatism. 62(4):1060-1068. doi:10.1002/art.27327 Landmark RCT demonstrating low-dose colchicine is as effective as high-dose with fewer side effects.
- Ozen S, et al. (2016). "EULAR/PRINTO/PRES criteria for Familial Mediterranean Fever." Annals of the Rheumatic Diseases. 75:644-651. International criteria for FMF diagnosis and colchicine treatment recommendations.
Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Recommendations are based on systematic reviews, randomized controlled trials, and international clinical guidelines from EULAR, ACR, and WHO.
iMedic Editorial Standards
Peer Review Process
All medical content is reviewed by at least two licensed specialist physicians before publication.
Fact-Checking
All medical claims are verified against peer-reviewed sources, approved prescribing information, and international guidelines.
Update Frequency
Content is reviewed and updated at least every 12 months or when new evidence or safety information emerges.
Corrections Policy
Any errors are corrected immediately with transparent changelog. Read more
Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in rheumatology, clinical pharmacology, internal medicine, and emergency medicine.